Literature DB >> 21804581

Partnering between pharma peers on the rise.

Asher Mullard.   

Abstract

Mesh：

Year:  2011        PMID： 21804581     DOI： 10.1038/nrd3526

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  5 in total

Review 1.  Pharmacogenomics in clinical practice and drug development.

Authors:  Andrew R Harper; Eric J Topol
Journal:  Nat Biotechnol       Date:  2012-11-08       Impact factor: 54.908

Review 2.  Challenges in translating academic research into therapeutic advancement.

Authors:  Gabriela Matos; Sergio Tufik; Monica Levy Andersen
Journal:  Front Neurol       Date:  2013-09-03       Impact factor: 4.003

3.  Key drivers of biomedical innovation in cancer drug discovery.

Authors:  Margit A Huber; Norbert Kraut
Journal:  EMBO Mol Med       Date:  2015-01       Impact factor: 12.137

Review 4.  Overcoming cancer therapeutic bottleneck by drug repurposing.

Authors:  Zhe Zhang; Li Zhou; Na Xie; Edouard C Nice; Tao Zhang; Yongping Cui; Canhua Huang
Journal:  Signal Transduct Target Ther       Date:  2020-07-02

5.  Etodolac Fortified Sodium Deoxycholate Stabilized Zein Nanoplatforms for Augmented Repositioning Profile in Human Hepatocellular Carcinoma: Assessment of Bioaccessibility, Anti-Proliferation, Pro-Apoptosis and Oxidant Potentials in HepG2 Cells.

Authors:  Ahmed K Kammoun; Maha A Hegazy; Alaa Khedr; Zuhier Ahmed Awan; Maan T Khayat; Majid Mohammad Al-Sawahli
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.